Open AccessAPOE and mild cognitive impairment: the Framingham Heart Study
Author(s) -
Angela L. Jefferson,
Alexa S. Beiser,
Sudha Seshadri,
Philip A. Wolf,
Rhoda Au
Publication year - 2014
Publication title -
age and ageing
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.014
H-Index - 143
eISSN - 1468-2834
pISSN - 0002-0729
DOI - 10.1093/ageing/afu183
Subject(s) - medicine , cognitive impairment , framingham heart study , dementia , framingham risk score , cognition , apolipoprotein e , gerontology , cardiology , psychiatry , disease
The risk apolipoprotein E-4 (APOE4) poses for mild cognitive impairment (MCI) may vary based on the neuropsychological definition of MCI.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom